In particular, this process may be achieved through the Wnt/β-catenin signaling pathway by inducing EMT, suggesting that CRIP1 may be an important biomarker for ovarian cancer metastasis and prognosis, as well as an important molecular target for ovarian cancer therapy. This evidence concerns the gene CRIP1 and ovarian cancer.